glutamic acid has been researched along with fluorouracil in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 6 (75.00) | 24.3611 |
2020's | 2 (25.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chen, X; Wang, Z; Yan, S; Yin, J; Zheng, Y; Zhu, J | 1 |
Matsushita, T; Oshikata, A; Ueoka, R | 1 |
Adamski, J; Halama, A; Hrabě de Angelis, M; Möller, G; Riesen, N | 1 |
André, T; Banzi, M; Bonnetain, F; Carlsson, GU; Chibaudel, B; Colote, S; de Gramont, A; Demetter, P; Duval, A; Fléjou, JF; Hickish, T; Landolfi, S; Louvet, C; Maartense, E; Möehler, M; Papamichael, D; Scheithauer, W; Scriva, A; Shmueli, E; Tabernero, J; Tijeras-Raballand, A; Tournigand, C; Van Laethem, JL; Vernerey, D | 1 |
Hong, D; Hong, KM; Kang, JH; Kim, SY; Lee, JS; Lee, SH; Son, J; Song, J | 1 |
Abdellatif, AAH; Aldubayan, MA; Alhowail, AH; Almogbel, YS; Chigurupati, S; Nemala, RA | 1 |
Amagase, K; Fujita, T; Fujiwara, A; Hamouda, N; Iwata, K; Jonan, S; Kato, S | 1 |
1 trial(s) available for glutamic acid and fluorouracil
Article | Year |
---|---|
Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III Colon Cancer: Updated 10-Year Survival and Outcomes According to BRAF Mutation and Mismatch Repair Status of the MOSAIC Study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Disease-Free Survival; DNA Mismatch Repair; Female; Fluorouracil; Follow-Up Studies; Glutamic Acid; Humans; Infusions, Intravenous; Injections, Intravenous; Kaplan-Meier Estimate; Leucovorin; Male; Middle Aged; Mutation; Neoplasm Staging; Odds Ratio; Organoplatinum Compounds; Prognosis; Proto-Oncogene Proteins B-raf; Treatment Outcome; Valine | 2015 |
7 other study(ies) available for glutamic acid and fluorouracil
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Layer-by-layer assembly of poly(L-glutamic acid)/chitosan microcapsules for high loading and sustained release of 5-fluorouracil.
Topics: Animals; Antimetabolites, Antineoplastic; Capsules; Cell Survival; Chitosan; Delayed-Action Preparations; Drug Carriers; Drug Compounding; Drug Delivery Systems; Excipients; Fibroblasts; Fluorouracil; Glutamic Acid; Mice; Pharmacokinetics; Solubility | 2011 |
Enhancement of drug efflux activity via MDR1 protein by spheroid culture of human hepatic cancer cells.
Topics: ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Culture Techniques; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Epirubicin; Fluorouracil; Glutamic Acid; Hep G2 Cells; Humans; Inhibitory Concentration 50; Spheroids, Cellular | 2011 |
Identification of biomarkers for apoptosis in cancer cell lines using metabolomics: tools for individualized medicine.
Topics: Alanine; Amino Acids; Apoptosis; Biomarkers; Carnitine; Caspase 3; Caspase 7; Cell Line, Tumor; Etoposide; Flow Injection Analysis; Fluorouracil; Glutamic Acid; HEK293 Cells; Hep G2 Cells; Humans; Metabolomics; Precision Medicine | 2013 |
Dual targeting of glutaminase 1 and thymidylate synthase elicits death synergistically in NSCLC.
Topics: A549 Cells; Adenosine Triphosphate; Animals; Aspartic Acid; Carcinoma, Non-Small-Cell Lung; Cell Cycle Checkpoints; Cell Death; Cell Proliferation; Cell Survival; Cytosol; Drug Synergism; Fluorouracil; Gene Knockdown Techniques; Glutamic Acid; Glutaminase; Glutamine; Lung Neoplasms; Malates; Mice, Inbred BALB C; Mice, Nude; Molecular Targeted Therapy; NAD; Oxidation-Reduction; Sulfides; Thiadiazoles; Thymidylate Synthase; Xenograft Model Antitumor Assays | 2016 |
Effects of CMF and MET on glutamate and dopamine levels in the brain, and their impact on cognitive function.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Brain; Breast Neoplasms; Cognition; Cyclophosphamide; Diabetes Mellitus, Type 2; Dopamine; Female; Fluorouracil; Glutamic Acid; Humans; Metformin; Methotrexate; Rats | 2022 |
Alleviative effects of glutamate against chemotherapeutic agent-induced intestinal mucositis.
Topics: Animals; Antimetabolites, Antineoplastic; Fluorouracil; Glutamic Acid; Intestinal Mucosa; Intestines; Mice; Mucositis; Rats | 2022 |